Matinas BioPharma Holdings, Inc. SEC filings MTNB
Matinas BioPharma Holdings, Inc. has 570 filings in SEC EDGAR's recent list, going back to Jul 25, 2013. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14A | Proxy statement | May 12, 2025 | May 12, 2025 |
| PRE 14A | Preliminary proxy statement | May 2, 2025 | May 2, 2025 |
| DEF 14A | Proxy statement | Mar 3, 2025 | Mar 3, 2025 |
| PRE 14A | Preliminary proxy statement | Feb 21, 2025 | Feb 21, 2025 |
| DEF 14A | Proxy statement | Sep 19, 2023 | Sep 19, 2023 |
| PRE 14A | Preliminary proxy statement | Sep 8, 2023 | Sep 8, 2023 |
| DEF 14A | Proxy statement | Sep 22, 2022 | Sep 22, 2022 |
| DEF 14A | Proxy statement | Sep 17, 2021 | Sep 17, 2021 |
| DEF 14A | Proxy statement | Dec 17, 2020 | Jan 26, 2021 |
| PRE 14A | Preliminary proxy statement | Dec 7, 2020 | Jan 26, 2021 |
| DEF 14A | Proxy statement | Oct 1, 2020 | Oct 1, 2020 |
| DEF 14A | Proxy statement | Sep 24, 2019 | Sep 24, 2019 |
| PRE 14A | Preliminary proxy statement | Sep 13, 2019 | Sep 13, 2019 |
| DEF 14A | Proxy statement | Sep 24, 2018 | Nov 1, 2018 |
| DEF 14A | Proxy statement | Sep 14, 2017 | Oct 25, 2017 |
| DEF 14A | Proxy statement | Sep 22, 2016 | Oct 13, 2016 |
| PRE 14A | Preliminary proxy statement | Sep 12, 2016 | Oct 13, 2016 |
| DEF 14A | Proxy statement | Sep 22, 2015 | Oct 29, 2015 |
| PRE 14A | Preliminary proxy statement | Sep 11, 2015 | Oct 29, 2015 |
Showing 19 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- MTNB (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Bedminster, NJ
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1582554
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.